Justin Balko on Activations in the JAK-STAT Pathway in Triple-Negative Breast Cancer

(3:18)

Justin Balko on JAK2 Amplification in Triple-Negative Breast Cancer

(1:40)

Justin Balko on the Diversity of Genetic Alterations in Triple-Negative Breast Cancer

(1:26)

The role of biomarkers in guiding treatment for early-stage breast cancer

(2:39)

Dr Justin Balko - \

(35:24)

Komen Mission Webinar: Dr. Justin Balko Explains T Cells (Clip 6 of 9)

(1:19)

Komen Mission Webinar: Dr. Justin Balko Discusses T-Cells and Breast Cancer (Clip 7 of 9)

(2:)

Komen Mission Webinar: Introducing Dr. Justin Balko (Clip 3 of 9)

(4:38)

Justin M Balko, Vanderbilt University, Nashville, TN, USA

(6:7)

Predictive biomarkers for immunotherapy outcome in breast cancer - Justin Balko, PharmD, PhD

(34:59)

Komen Mission Webinar: Dr. Justin Balko Discusses Immunotherapy (Clip 5 of 9)

(1:14)

What future does ctDNA have as a biomarker in breast cancer?

(42)

Prognostic biomarkers of immunotherapy efficacy in breast cancer

(55)

Komen Mission Webinar: Dr. Justin Balko on Triple Negative Breast Cancer (Clip 4 of 9)

(3:48)

Elucidating immunotherapy biomarkers for breast cancer

(1:3)

Experts Discuss Melanoma Research

(1:1:23)

Is it possible to predict who will benefit the most from IO in TNBC?

(3:55)

Single-cell analyses of checkpoint-inhibition-induced myocarditis: implications into mechanisms....

(47:25)

Endocrine Resistance: Mechanisms and Treatment Strategies

(21:19)

Workshop: Clinical Research \

(23:52)